Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus sufentanil for surgeon and patient satisfaction in stereotactic surgery
IRCT20190506043487N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Oct 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine and sufentanil in None (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Surgeon satisfaction and Patient satisfaction. Started Oct 2017; status: completed.
02
Drugs
dexmedetomidinesufentanil
Beyond the preview
Go deeper on IRCT20190506043487N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190506043487N1.